India's National Pharmaceutical Pricing Authority has rejected applications for increases in the prices of several imported drugs. "We have retained the existing prices of these imported products because these companies could not justify a required price increase. We believe the landed cost remains the same. Even if it has increased, only the margins would shrink a little. So, there is no need for a price revision," an official said.

Related Summaries